Medicine recalls
|
| |
| The United Kingdom: Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Lucentis 10 mg／ml solution for injection in pre-filled syringe |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Novartis Pharmaceuticals UK is recalling one batch of Lucentis 10 mg/ml solution for injection in pre-filled syringe (ranibizumab) (batch number: 21B15IA) due to a faulty plunger stopper which has led to an increased number of customer complaints relating to the plunger being difficult to press down. The faulty plunger stopper batch has only been used in batch 21B15IA and no other batches of Lucentis are impacted.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-2-medicines-recall-novartis-pharmaceuticals-uk-lucentis-10-mg-slash-ml-solution-for-injection-in-pre-filled-syringe-el-21-a-slash-36
In Hong Kong, Lucentis Solution For Injection In Pre-filled Syringe 10mg/ml (HK-63860) is a pharmaceutical product registered by Novartis Pharmaceuticals (HK) Limited (Novartis). The product is a prescription-only medicine. As confirmed with Novartis, the affected batch has not been imported into Hong Kong.
Ends/Tuesday, Dec 14, 2021
Issued at HKT 15:00
|
| |
